Xeris Pharmaceuticals, Inc.
6 drugs in NADAC|0 Generic,6 Brand
Xeris Pharmaceuticals, Inc. lists 6 NDCs in the CMS NADAC file (0 generic, 6 brand), at an average NADAC of $1868.00 per unit, with a week-over-week move of -0.1% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
6
0G / 6B
Avg Price / Unit
$1867.9980
$1596.19 – $3202.33
Avg 7d Change
-0.11%
Across 5 drugs with changes
7d Activity
of 6 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
glucagon injection, solution market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Antihypoglycemic Agent therapeutic class
Review the broader class where Xeris Pharmaceuticals, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Xeris Pharmaceuticals, Inc. make?
Xeris Pharmaceuticals, Inc. lists 6 NDCs in the CMS NADAC file — 0 generic and 6 brand products.
What is the average price of Xeris Pharmaceuticals, Inc. drugs?
The average NADAC across Xeris Pharmaceuticals, Inc.'s portfolio is $1867.9980 per unit, ranging from $1596.1935 to $3202.3299.
What types of drugs does Xeris Pharmaceuticals, Inc. make?
Xeris Pharmaceuticals, Inc. makes drugs across 2 FDA pharmacologic classes. The most common by NDC count are Antihypoglycemic Agent (6), Gastrointestinal Motility Inhibitor (6).
Has Xeris Pharmaceuticals, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Xeris Pharmaceuticals, Inc. in the openFDA feed.
How has Xeris Pharmaceuticals, Inc.'s pricing changed recently?
Over the past 7 days, 1 Xeris Pharmaceuticals, Inc. product rose and 4 fell, with a portfolio-wide average change of -0.1%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
GVOKE HYPOPEN 2PK 0.5 MG/0.1 ML glucagon injection, solution | $3202.3299 per ML | -0.03% |
GVOKE PFS 2-PK 1 MG/0.2 ML SYR glucagon injection, solution | $1604.3393 per ML | -0.12% |
GVOKE HYPOPEN 1-PK 1 MG/0.2 ML glucagon injection, solution | $1603.1823 per ML | -0.02% |
GVOKE 1 MG/0.2 ML KIT glucagon injection, solution | $1600.9864 per ML | — |
GVOKE PFS 1-PK 1 MG/0.2 ML SYR glucagon injection, solution | $1600.9565 per ML | +0.05% |
GVOKE HYPOPEN 2-PK 1 MG/0.2 ML glucagon injection, solution | $1596.1935 per ML | -0.45% |